Skip to search formSkip to main contentSkip to account menu

Antihemophilic Factor, Human Recombinant 1 UNT Injection [Advate]

Known as: Advate 1 UNT Injection, ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT 50 [iU] in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ADVATE], ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT 800 [iU] in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ADVATE] 
National Institutes of Health

Related topics

Related topics

13 relations
AdvateAntihemophilic Factor, Human RecombinantCalcium ChlorideFactor VIII

Broader (1)

Antihemophilic Factor, Human Recombinant 1 UNT Injection

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Society on Thrombosis and Haemostasis Kioto ( Japonia ) , 23 – 28 lipca 2011 roku
Nowe rekombinowane białka Rekombinowany czynnik VIII Powell i wsp. przedstawili wyniki otwartego, wieloośrodkowego badania z… 
2009
2009
Xyntha® is effective and safe in previously treated patients with severe haemophilia A: Final results of a pivotal phase III study
Background:  Xyntha® (albumin-free cell culture process) is a BDDrFVIII manufactured using an albumin-free cell culture process…